Amgen Joins China Oncology Market Race With $2.7bn BeiGene Stake

 
• By Brian Yang
China
AMGEN INVESTS $2.7bn IN BEIJING-BASED BEIGENE TO SEIZE CHINA ONCOLOGY MARKET OPPORTUNITIES • Source: Shutterstock

More from China

More from Focus On Asia